1. Catalog
  2. Psychedelics in the Treatment of Substance Use Dis ...
Image For Activity Cover
Psychedelics in the Treatment of Substance Use Disorders: What Clinicians Need to Know (Enduring Material)
Requirements for Successful Activity Completion
In order to successfully complete this activity and obtain your credit certificate:

Course Content
1. Watch the recording.
2. Complete the post-test and receive a passing rate of 70%.
3. Click Evaluation to complete the final course evaluation (2-3 minutes).
4. Follow instructions at the end of the course regarding how to retrieve a certificate.
5. If you have any questions or you do not receive your certificate, please email cmecpd@aaap.org
6. 30 days following your completion of this activity, you will receive a survey (2 questions) to ask about changes in your practice.
Learning Objectives
At the conclusion of this session, participants will
  • Review and examine the latest clinical data investigating the use of psychedelics to treat various substance use disorders, including the limitations of the data.
  • Describe the subjective experiences of psychedelics as reported by clinical trial participants.
  • Determine the rationale for studying psychedelic use in the context of psychotherapy.
  • Examine the risks and benefits of utilization in patient therapy. Provide tools to communicate with patients about risks and informed consent.
Who Should Participate?
This activity was designed for physicians and other healthcare professionals and is designated for learners in the following ways:

Physicians
American Academy of Addiction Psychiatry designates this enduring material activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Healthcare Professionals

Participants will receive a certificate stating this program is designated for 1.5 AMA PRA Category 1 Credits™. This credit is accepted by the AANP and the AAPA.
Faculty



Part 1: Psilocybin in the treatment of substance use disorders

Presenter:
Christopher Pittenger, MD, PhD
Director, Yale Program for Psychedelic Science, Psychiatry; Director, Yale Center for Brain and Mind Health, Yale School of Medicine; Director, Yale OCD Research Clinic, Psychiatry; Director, Neuroscience Research Training Program Yale Department of Psychiatry
New Haven, Connecticut

 



Part 2: Reviewing the Design, Outcomes, and the Limitations of the Studies/Data Collection of Large Randomized Controlled Trials

Presenter:
Suresh Muthukumaraswamy, PhD 

Associate Professor 

School of Pharmacy

Faculty of Medical and Health Sciences

The University of Auckland 

Waipapa Taumata Rau

 



Part 3: Ethical Considerations and Concerns About Patient Safety When Treating with Psychedelics 

Presenter:
Paul Appelbaum, MD 

Psychiatry, Forensic Psychiatry 

Elizabeth K. Dollard Professor of Psychiatry, Medicine and Law, and Director, Division of Law, Ethics and Psychiatry at Columbia  

New York, New York


 

 

 



Panel discussion 

Moderator:
Karen Drexler, MD

Medical Director, AAAP

Department of Psychiatry and Behavioral Sciences Associate Professor 

Emory University School of Medicine 

Atlanta, Georgia

 
         

Panelist:
Nora Volkow, MD 

Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health





Panelist:
Bertha Madras, PhD 

Professor of Psychobiology 

Harvard Medical School

McLean Hospital

Boston, Massachusetts 
Summary
Availability: On-Demand
Expires on Jun 01, 2026
Cost: Member: $25.00
Non-Member: $50.00
Credit Offered:
1.5 CME Credits
1.5 Other Professionals Credits
Create Account
Recommended
 
American Academy of Addiction Psychiatry
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

  
400 Massasoit Avenue
Suite 307
East Providence, RI 02914
cmecpd@aaap.org
About
Advocacy
Membership
Fellowship
Education and Resources
Training Events
 
Powered By